Robyn Mitchell

Robyn Mitchell

Auto-generated profile, based on publicly available information

Robyn Mitchell

Public Health Agency of Canada

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in American Journal of Infection Control
Verified
Journal Article
Closed access
RMRobyn Mitchell
Robyn Mitchell
VRVirginia Roth
Virginia Roth
DGDenise Gravel
Denise Gravel
GAGeorge Astrakianakis
George Astrakianakis
EBElizabeth Bryce
Elizabeth Bryce
MVMary Vearncombe
Mary Vearncombe

1 September 2012 in American Journal of Infection Control
Verified
Journal Article
Closed access
RMRobyn Mitchell
Robyn Mitchell
TOToju Ogunremi
Toju Ogunremi
GAGeorge Astrakianakis
George Astrakianakis
EBElizabeth Bryce
Elizabeth Bryce
RGRobert Gervais
Robert Gervais
CWChristine Weir
Christine Weir

3 April 2023 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
RMRobyn Mitchell
Robyn Mitchell
JCJoelle Cayen
Joelle Cayen
NTNisha Thampi
Nisha Thampi
CFCharles Frenette
Charles Frenette
JBJessica Bartoszko
Jessica Bartoszko
LPLinda Pelude
Linda Pelude
The clinical presentation of COVID-19 can range from asymptomatic infection to mild, moderate, severe, or critical disease. Severe and critical disease occur more often in older persons and/or those with preexisting comorbidities1 as well as those who lack immunity either through vaccination or prior infection.2-5 Changes in severe outcomes have significant implications for the health care system. Therefore, it is important to monitor trends in severe outcomes associated with COVID-19 to inform public health measures.

1 November 2013 in American Journal of Infection Control
Verified
Journal Article
Closed access
RMRobyn Mitchell
Robyn Mitchell
GTGeoffrey Taylor
Geoffrey Taylor
AMAllison McGeer
Allison McGeer
CFCharles Frenette
Charles Frenette
KSKathryn N. Suh
Kathryn N. Suh
DGDenise Gravel
Denise Gravel

4 August 2025 in Microbial Genomics
Verified
Journal Article
Open access
NLNicole Lerminiaux
Nicole Lerminiaux
KFKen Fakharuddin
Ken Fakharuddin
YLYves Longtin
Yves Longtin
EMErin McGill
Erin McGill
RMRobyn Mitchell
Robyn Mitchell
OPOn Behalf Of The Canadian Nosocomial Infection Surveillance Program
On Behalf Of The Canadian Nosocomial Infection Surveillance Program
Carbapenems are broad-spectrum antibiotics that are losing effectiveness against infections caused by multidrug-resistant Enterobacterales that have acquired carbapenemase genes. The New Delhi metallo-β-lactamase (bla NDM) is one of the most common carbapenemases in Canada and around the globe. These genes are frequently found on conjugative plasmids, which can disseminate through horizontal gene transfer. We applied whole-genome sequencing to characterize 1,032 bla NDM carbapenemase-producing Enterobacterales isolates collected by the Canadian Nosocomial Infection Surveillance Program from 2010 to 2023. Using a combination of short-read and long-read sequencing, we obtained 226 complete and circular bla NDM-encoding plasmids. Unlike other carbapenemases in Canada, we found that bla NDM plasmids were very diverse; there was a lack of dominant clusters identified using MOB-suite, and clustering methods were not able to accurately predict plasmid clusters for short-read-only data. The majority of bla NDM plasmids were IncF-type (69.0%, 156/226). Both bla NDM and bla OXA-48-type carbapenemase genes were found in 11.4% (118/1,032) of isolates, and we identified several instances of both carbapenemase genes co-harboured on the same plasmid replicon (n=9). Our findings highlight that plasmid transfer has not played a major role in bla NDM transmission across Canada and that long-read sequencing is essential for resolving bla NDM plasmid structure and cluster membership.

10 January 2014 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
TPThe Canadian Nosocomial Infection Surveillance Program
The Canadian Nosocomial Infection Surveillance Program
GTGeoffrey Taylor
Geoffrey Taylor
RMRobyn Mitchell
Robyn Mitchell
RFRachel Fernandes
Rachel Fernandes
AMAllison McGeer
Allison McGeer
DGDenise Gravel
Denise Gravel
Multiple observational studies have associated antiviral treatment of patients hospitalized with influenza with improved outcome, including reduced mortality. During the 2009–2010 H1N1 pandemic increased use of antiviral treatment of hospital patients was reported. We have carried out prospective surveillance for influenza in patients in a large network of Canadian hospitals since 2006. We wished to assess trends in antiviral use in the two seasons (2010–2011 and 2011–2012) since the end of the pandemic.